Controversial Bollywood Movie Padmaavat To Re-Release In Theatres: Check Why It Was Banned In Malaysia
“Experience the tyranny of Alauddin Khilji on the big screen! 'Padmaavat' is returning to theatres! Don't miss the re-release... in cinemas on the 6th of February!” the actor wrote on Instagram while sharing a movie poster.
Padmaavat controversyBollywood film Padmaavat faced major controversy over its historical accuracy and portrayal of women. The movie faced delays and violent protests across India. Critics alleged that the film distorted history and showed Queen Padmavati in a negative light.
Also Read | Satya re-release: Bhiku Mhatre returns after 26 years; check whenHistorians, however, stated that her existence lacks solid evidence. Queen Padmavati is not a real character but a fictional one from the epic poem Padmavat, some argued. The poem was written in 1540 by Sufi poet Malik Muhammad Jayasi.
Political parties in India had differing opinions on the film, further fueling the debate. The situation escalated with threats of violence and death directed at the film's director, Sanjay Leela Bhansali, and lead actress, Deepika Padukone.
Also Read | Yeh Jawaani Hai Deewani Re-Release: Social media reacts, all-time favouriteThe Central Board of Film Certification (CBFC ) approved the film after suggesting changes. One major modification was renaming it from Padmavati to Padmaavat to highlight its fictional basis.
Despite the changes, the film was banned in Malaysia due to its portrayal of a Muslim ruler in a negative manner. Some also accused the film of promoting misogyny. Padmaavat was eventually released on January 25, 2018.
Ranveer Singh and Deepika Padukone, who were dating during the movie play the lead roles in the movie, along with Shahid Kapoor. Ranveer-Deepika got married in November 2018. Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment